DLB Dolby Laboratories, Inc.
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.…
Industry Peers
Specialty Business ServicesKey Statistics
About Dolby Laboratories (NYSE: DLB)
›
Dolby Laboratories (NYSE: DLB) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Business Services industry, part of the Industrials sector, and reports about 2,000 employees.
The shares were at 55.33 USD on 20 November 2026, down 12.8% over 52 weeks. Its 52-week range is 48.26 USD to 69.95 USD: the price is 20.9% below the high and 14.6% above the low.
At a market capitalisation of 5.18B USD, it trades at 20.5 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 20 largest Specialty Business Services peers is 28.9, a discount of 29% for DLB. It pays a dividend yielding 2.85% (it pays out 53% of its earnings), against a median of 2.32% among the dividend payers in that peer group.
Dolby Laboratories reports return on equity of 9.7%, an operating margin of 22.5% and revenue up 21.7% year over year.
It holds more cash than debt, a net cash position of 577.58M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 71.67 USD is 29.5% above the current price.